Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-08-19

FDA Approved: RAMELTEON — Original Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved ramelteon (Actavis Pharma) for treatment of insomnia characterized by difficulty with sleep onset.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ramelteon (ramelteon)

Snippet

ORIG AP for RAMELTEON (RAMELTEON)